CollPlant Completes Acquisition of LightSolver, Entering Photonic Computing Sector

On September 3, 2026, CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) announced the successful closing of its acquisition of LightSolver Ltd., an Israeli deep-tech company specializing in photonic computing. This strategic move marks CollPlant's entry into the high-performance computing (HPC) and photonics sectors, diversifying its business beyond its core focus on regenerative medicine and 3D bioprinting. LightSolver is developing a Laser Processing Unit (LPU), an energy-efficient computing platform designed for computationally intensive workloads in aerospace, defense, and finance. Under the terms of the equity-centric agreement, CollPlant issued upfront ordinary shares and pre-funded warrants, and made a $5 million investment in LightSolver. Additionally, milestone-based warrants were issued, which will become exercisable upon LightSolver's achievement of specific technological and commercial objectives. The acquisition is intended to accelerate the commercialization of LightSolver's LPU platform. CollPlant will continue its active operations in regenerative medicine, including its recombinant human collagen technology, while operating the new photonics business in parallel.